Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Szumlanski

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1991
Human liver xanthine oxidase: nature and extent of individual variationR Guerciolini, C Szumlanski, R M Weinshilboum
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 31, 1990
Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variationJ Rini, C Szumlanski, R Guerciolini, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Human liver catechol-O-methyltransferase pharmacogeneticsB Boudíková, C Szumlanski, B Maidak, et al.
Agents and Actions|March 1, 1991
Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variationM C Scott, R Guerciolini, C Szumlanski, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 24, 1998
Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiencyJ B Andersen, C Szumlanski, R M Weinshilboum, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1996
Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variationC Her, C Szumlanski, I A Aksoy, et al.
Life Sciences|January 1, 1992
Electrophoretic analysis of low and high activity forms of catechol-O-methyltransferase in human erythrocytesM H Grossman, C Szumlanski, J B Littrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile formR S Sundaram, C Szumlanski, D Otterness, et al.
Clinical Neuropharmacology|July 15, 2000
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's diseaseD J Chong, O Suchowersky, C Szumlanski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1D Lee, C Szumlanski, J Houtman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|December 1, 1991
Human liver xanthine oxidase: nature and extent of individual variationR Guerciolini, C Szumlanski, R M Weinshilboum
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 31, 1990
Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variationJ Rini, C Szumlanski, R Guerciolini, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Human liver catechol-O-methyltransferase pharmacogeneticsB Boudíková, C Szumlanski, B Maidak, et al.
Agents and Actions|March 1, 1991
Mouse kidney histamine N-methyltransferase: assay conditions, biochemical properties and strain variationM C Scott, R Guerciolini, C Szumlanski, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 24, 1998
Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiencyJ B Andersen, C Szumlanski, R M Weinshilboum, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 1996
Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variationC Her, C Szumlanski, I A Aksoy, et al.
Life Sciences|January 1, 1992
Electrophoretic analysis of low and high activity forms of catechol-O-methyltransferase in human erythrocytesM H Grossman, C Szumlanski, J B Littrell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile formR S Sundaram, C Szumlanski, D Otterness, et al.
Clinical Neuropharmacology|July 15, 2000
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's diseaseD J Chong, O Suchowersky, C Szumlanski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1995
Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1D Lee, C Szumlanski, J Houtman, et al.
Pageof 2